- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x MN: MANGANESE (II) ION(Non-covalent)
- 6 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.3: 11 residues within 4Å:- Chain A: H.115, D.138, H.140, D.142, H.155, D.246, D.248, T.260, E.291
- Ligands: MN.1, MN.2
6 PLIP interactions:6 interactions with chain A- Salt bridges: A:D.138, A:D.142, A:D.246, A:D.248, A:E.291
- pi-Cation interactions: A:H.155
DMS.4: 4 residues within 4Å:- Chain A: S.29, Q.32, K.33, N.83
No protein-ligand interaction detected (PLIP)DMS.8: 11 residues within 4Å:- Chain B: H.115, D.138, H.140, D.142, H.155, D.246, D.248, T.260, E.291
- Ligands: MN.6, MN.7
6 PLIP interactions:6 interactions with chain B- Salt bridges: B:D.138, B:D.142, B:D.246, B:D.248, B:E.291
- pi-Cation interactions: B:H.155
DMS.9: 4 residues within 4Å:- Chain B: G.221
- Chain C: D.218, R.219, G.221
No protein-ligand interaction detected (PLIP)DMS.13: 11 residues within 4Å:- Chain C: H.115, D.138, H.140, D.142, H.155, D.246, D.248, T.260, E.291
- Ligands: MN.11, MN.12
6 PLIP interactions:6 interactions with chain C- Salt bridges: C:D.138, C:D.142, C:D.246, C:D.248, C:E.291
- pi-Cation interactions: C:H.155
DMS.14: 5 residues within 4Å:- Chain C: Q.210, Y.211, F.212, D.216, R.228
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:Y.211
- Salt bridges: C:D.216
- 3 x PRO: PROLINE(Non-covalent)
PRO.5: 6 residues within 4Å:- Chain A: H.140, N.144, S.151, G.156, D.195, D.197
10 PLIP interactions:1 Ligand-Ligand interactions, 9 interactions with chain A- Water bridges: P.5, A:D.142, A:T.149, A:T.149, A:S.151, A:S.151, A:S.151, A:N.153
- Hydrogen bonds: A:N.144, A:S.151
PRO.10: 7 residues within 4Å:- Chain B: H.140, N.144, S.151, N.153, G.156, D.195, D.197
10 PLIP interactions:8 interactions with chain B, 2 Ligand-Ligand interactions- Hydrophobic interactions: B:H.140
- Hydrogen bonds: B:N.144, B:S.151, B:D.197, B:E.200, P.10, P.10
- Water bridges: B:T.149, B:N.153, B:N.153
PRO.15: 7 residues within 4Å:- Chain C: H.140, N.144, S.151, N.153, G.156, D.195, D.197
10 PLIP interactions:9 interactions with chain C, 1 Ligand-Ligand interactions- Hydrophobic interactions: C:H.140
- Hydrogen bonds: C:N.144, C:S.151, C:E.200, P.15
- Water bridges: C:S.151, C:S.151, C:S.151, C:N.153, C:G.156
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mlynarski, S.N. et al., Discovery of (2 R ,4 R )-4-(( S )-2-Amino-3-methylbutanamido)-2-(4-boronobutyl)pyrrolidine-2-carboxylic Acid (AZD0011), an Actively Transported Prodrug of a Potent Arginase Inhibitor to Treat Cancer. J.Med.Chem. (2024)
- Release Date
- 2024-12-04
- Peptides
- Arginase-2, mitochondrial: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x MN: MANGANESE (II) ION(Non-covalent)
- 6 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 3 x PRO: PROLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mlynarski, S.N. et al., Discovery of (2 R ,4 R )-4-(( S )-2-Amino-3-methylbutanamido)-2-(4-boronobutyl)pyrrolidine-2-carboxylic Acid (AZD0011), an Actively Transported Prodrug of a Potent Arginase Inhibitor to Treat Cancer. J.Med.Chem. (2024)
- Release Date
- 2024-12-04
- Peptides
- Arginase-2, mitochondrial: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C